Fengchao Jiang

614 total citations
39 papers, 503 citations indexed

About

Fengchao Jiang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Fengchao Jiang has authored 39 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Fengchao Jiang's work include Immune Response and Inflammation (8 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Fengchao Jiang is often cited by papers focused on Immune Response and Inflammation (8 papers), Alzheimer's disease research and treatments (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Fengchao Jiang collaborates with scholars based in China, United States and Japan. Fengchao Jiang's co-authors include Limin Zhang, Mingqiang Li, Wentao He, Ping Zhou, Ping Zhou, Lei Li, Jianhua Liu, Jianguo Chen, Xue Zhang and Hui Guo and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and The Plant Journal.

In The Last Decade

Fengchao Jiang

35 papers receiving 498 citations

Peers

Fengchao Jiang

IMMUN

PHARM

SURGE

Antonio Lapenna United Kingdom

Asma Kheirollahi Iran

Yuhong Sun China

Pengke Yan China

Heon‐Woo Lee South Korea

Nasim Dana Iran

Joon‐Suk Park South Korea

Lingyan Jian China

Liyun Liu China

Yiu To Yeung China

Antonio Lapenna United Kingdom

Fengchao Jiang

185 ×1.2

136 ×1.1

IMMUN

32 ×0.4

PHARM

75 ×1.1

41 ×0.7

SURGE

Citations per year, relative to Fengchao Jiang Fengchao Jiang (= 1×) peers Antonio Lapenna

Countries citing papers authored by Fengchao Jiang

Since Specialization

Citations

This map shows the geographic impact of Fengchao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengchao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengchao Jiang more than expected).

Fields of papers citing papers by Fengchao Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengchao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengchao Jiang. The network helps show where Fengchao Jiang may publish in the future.

Co-authorship network of co-authors of Fengchao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengchao Jiang. A scholar is included among the top collaborators of Fengchao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengchao Jiang. Fengchao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Fengchao, et al.. (2025). Large-Scale Screening and Identification of S-RNase Alleles in Chinese and European Apricot Accessions Reveal Their Diversity and Geographic Distribution Patterns. International Journal of Molecular Sciences. 26(17). 8667–8667.

Jiang, Fengchao, et al.. (2025). Rootstock Breeding of Stone Fruits Under Modern Cultivation Regime: Current Status and Perspectives. Plants. 14(9). 1320–1320. 2 indexed citations

Li, Zeyang, Ming‐Hui Zhao, Yang Yang, et al.. (2024). Treatment of a MyD88 inhibitor alleviates rejection and inflammation in xenotransplantation by inhibiting dendritic cells activation and trained immunity in macrophages. International Immunopharmacology. 130. 111664–111664. 3 indexed citations

Han, Jianzhong, Qian Wang, Peng Wang, et al.. (2024). Development of a novel humanized anti-TSLP monoclonal antibody HZ-1127 with anti-allergic diseases and cancer potential. PubMed. 7(2). 123–130. 1 indexed citations

Li, Zeyang, Ming‐Hui Zhao, Xiaoqian Zhang, et al.. (2022). TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway. Frontiers in Pharmacology. 13. 1080438–1080438. 6 indexed citations

Ye, Jian, Ting Feng, Fengchao Jiang, et al.. (2022). Adaptor protein MyD88 confers the susceptibility to stress via amplifying immune danger signals. Brain Behavior and Immunity. 108. 204–220. 11 indexed citations

Yang, Min, Gen Chen, Xue Zhang, et al.. (2018). A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice. Transplant Immunology. 53. 1–6. 4 indexed citations

Du, Dunfeng, Yang Yang, Min Yang, et al.. (2018). Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice. International Immunopharmacology. 67. 356–365. 17 indexed citations

Zhang, Yu, Zhuoyi Wang, Hao Gong, et al.. (2018). Menadione sodium bisulfite inhibits the toxic aggregation of amyloid-β(1–42). Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(10). 2226–2235. 22 indexed citations

10.

Jiang, Fengchao, Lijuan Ma, Rui Cai, et al.. (2017). Efficient crude multi-enzyme produced by Trichoderma reesei using corncob for hydrolysis of lignocellulose. 3 Biotech. 7(5). 339–339. 9 indexed citations

11.

Zhang, Xue, Mingqiang Li, Limin Zhang, et al.. (2016). Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice. Metabolism. 65(9). 1267–1277. 14 indexed citations

12.

Liu, Jianmin, Pengfei Wu, Jun Zhou, et al.. (2016). ST09, a Novel Thioester Derivative of Tacrine, Alleviates Cognitive Deficits and Enhances Glucose Metabolism in Vascular Dementia Rats. CNS Neuroscience & Therapeutics. 22(3). 220–229. 14 indexed citations

13.

Li, Lei, Ming Chen, & Fengchao Jiang. (2016). Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity. Bioorganic & Medicinal Chemistry. 24(8). 1853–1865. 19 indexed citations

14.

Zhang, Limin, Jianhua Liu, Mingqiang Li, et al.. (2016). Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro. Scientific Reports. 6(1). 26954–26954. 29 indexed citations

15.

Jiang, Fengchao, Limin Zhang, Wentao He, et al.. (2015). Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer. JNCI Journal of the National Cancer Institute. 108(4). djv364–djv364. 78 indexed citations

16.

Wang, Yue, Fang Wang, Junping Yu, et al.. (2012). Novel multipotent phenylthiazole–tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca2+ overload. Bioorganic & Medicinal Chemistry. 20(21). 6513–6522. 23 indexed citations

17.

Jiang, Fengchao. (2009). [The multi-target drugs and their design].. PubMed. 44(3). 282–7.

18.

Jiang, Fengchao, et al.. (2006). Pharmacophore Model Construction of <i>γ</i>-secretase Inhibitor. Acta Physico-Chimica Sinica. 22(3). 359–364. 3 indexed citations

19.

Dong, Mingxin, et al.. (2006). Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice. Neuroscience Letters. 405(1-2). 137–141. 16 indexed citations

20.

Jiang, Fengchao. (2004). Advances in the study of farnesyltransferase inhibitors. Zhongguo xin yao zazhi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact